James Jefferson Smith

USPTO Granted Patents = 60 (Patent Applications = 90)

EPO Patents = 33 (Patent Applications = 62)

Average Co-Inventor Count = 3.3

ph-index = 12

Forward Citations = 667(Granted Patents)

Forward Citations (Not Self Cited) = 463(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Lindenwold, NJ (US) (1982)
Durham, NC (US) (2011 - 2022)
Morrisville, NC (US) (2012 - 2024)

Company Filing History:

40 out of 48

Precision Biosciences, Inc.

Pioneer Hi-bred International, Inc.

patents

4. 5 out of 16,338

E.i. Dupont De Nemours and Company

patents

5. 1 out of 470

Colorado State University Research Foundation

patents

6. 1 out of 103

Corteva Agriscience LLC

8. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1982-2025

Loading Chart...

60 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12448613 - Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene (2025-10-21),

2. 12410418 - Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome (2025-09-09),

3. 12351839 - Rationally-designed single-chain meganucleases with non-palindromic recognition sequences (2025-07-08),

4. 12338444 - Methods for producing a complex transgenic trait locus (2025-06-24),

5. 12006522 - Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene (2024-06-11),

6. 11993793 - Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene (2024-05-28),

7. 11866747 - Engineered meganucleases that target human mitochondrial genomes (2024-01-09),

8. 11788077 - Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome (2023-10-17),

9. 11786554 - Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene (2023-10-17),

10. 11753630 - Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene (2023-09-12),

11. 11680254 - Engineered meganucleases specific for recognition sequences in the PCSK9 gene (2023-06-20),

12. 11459576 - Methods for producing a complex transgenic trait locus (2022-10-04),

13. 11278632 - Engineered nucleases useful for treatment of hemophilia A (2022-03-22),

14. 11274285 - Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome (2022-03-15),

15. 11268065 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene (2022-03-08),

Title: The Innovative Journey of James Jefferson Smith

Introduction:

James Jefferson Smith, a pioneering inventor based in Durham, NC, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents:

Smith's latest patents include a cutting-edge software application for data encryption, a revolutionary medical device for remote patient monitoring, and a sustainable energy solution for urban environments.

Career Highlights:

With a career spanning over two decades, James Jefferson Smith has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized with multiple awards in the technology and innovation sectors.

Collaborations:

Smith has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His partnerships have led to the successful commercialization of several products that have had a positive impact on various industries.

Conclusion:

In conclusion, James Jefferson Smith's relentless pursuit of innovation and his passion for creating solutions to complex problems have solidified his reputation as a trailblazing inventor in the technology landscape. His work continues to inspire future generations of inventors to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.